Atlas Trials

PhI to Solid Tumors and PhII to Locally Advanced or mTNBC

Clinical trial NCT05390710 · COMPLETED

Trial details

NCT number
NCT05390710
Sponsor
Laekna Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorTNBC - Triple-Negative Breast Cancer
Start date
2021-06-12
Primary completion
2023-12-11
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.